US Patent 7122526 Indolocarbazole anticancer agents and methods of using same
Patent 7122526 was granted and assigned to Nanosphere on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Michael T. Flavin0
Yasheen Zhou0
Ze-Qi Xu0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+233 characters)
Article
Patent abstract
The present invention relates to anti-tumor compounds, compositions and methods. In particular, the invention relates to indolocarbazole analogues of the following general formulas that inhibit topoisomerase I activity
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07122526 Indolocarbazole anticancer agents and methods of using same US Patent 7122526 Indolocarbazole anticancer agents and methods of using same
Infobox
Patent Number
07122526
Patent Number
7122526
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07122526 Indolocarbazole anticancer agents and methods of using same
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07122526
Date of patent
October 17, 2006
Patent application number
10610290
Date Filed
June 30, 2003
Patent primary examiner
Find more entities like US Patent 7122526 Indolocarbazole anticancer agents and methods of using same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
